The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The GCC biopsy devices market is currently witnessing moderate growth. Biopsy devices comprise equipment such as aspiration needles, forceps, and localization wires. They are used to extract tissues or cells from an organ by medical practitioners, radiologists, cardiologists, and surgeons to determine the presence of cancerous diseases. They are widely employed in MRI-guided, needle-based, vacuum, and core assisted biopsies of different body parts. As a result, the demand for biopsy devices is escalating across the GCC region.
The biopsy devices market is currently gaining immense popularity in the GCC region due to the emergence of advanced biopsy devices for diagnosing cancer. Moreover, government authorities in the region are introducing medical schemes and policies to support the utilization of biopsy devices. Furthermore, increasing investments in research and development (R&D) activities, in confluence with the advancing technologies in the healthcare sector, are positively influencing the market. However, the sudden outbreak of the coronavirus disease (COVID-19) pandemic has drastically shifted the focus of healthcare personnel towards treating COVID-19 patients. The market is projected to experience growth once the pandemic comes under control. Looking forward, the market is expected to continue its moderate growth during the forecast period (2021-2026).
IMARC Group provides an analysis of the key trends in each sub-segment of the GCC biopsy devices market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, procedure type, product, application, guidance technique and end user.
Breakup by Procedure Type:
Breakup by Product:
Breakup by Application:
Breakup by Guidance Technique:
Breakup by End User:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at